Boudny, M., Zemanova, J., Khirsariya, P., Borsky, M., Verner, J., Cerna, J., . . . Trbusek, M. (2019). Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells. Haematologica.
Citação norma ChicagoBoudny, Miroslav, et al. "Novel CHK1 Inhibitor MU380 Exhibits Significant Single-agent Activity in TP53-mutated Chronic Lymphocytic Leukemia Cells." Haematologica 2019.
Citação norma MLABoudny, Miroslav, et al. "Novel CHK1 Inhibitor MU380 Exhibits Significant Single-agent Activity in TP53-mutated Chronic Lymphocytic Leukemia Cells." Haematologica 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.